<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2016-1-83-90</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-623</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзор литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Literature Reviews</subject></subj-group></article-categories><title-group><article-title>ПРОБЛЕМЫ ОБЕСПЕЧЕНИЯ ИНФЕКЦИОННОЙ БЕЗОПАСНОСТИ ОРГАННОГО И ТКАНЕВОГО ДОНОРСТВА ПРИ ЛАБОРАТОРНОЙ ДИАГНОСТИКЕ ГЕМОКОНТАКТНЫХ ВИРУСНЫХ ИНФЕКЦИЙ</article-title><trans-title-group xml:lang="en"><trans-title>THE PROBLEMS OF PROVIDING INFECTIOUS DISEASE SAFETY FOR ORGAN AND TISSUE DONATION BY SCREENING BLOOD-BORNE VIRAL INFECTIONS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хубутия</surname><given-names>М. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Khubutiya</surname><given-names>M. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>129090, Москва, Б. Сухаревская пл., д. 3</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">solonin@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солонин</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Solonin</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>129090, Москва, Б. Сухаревская пл., д. 3</p></bio><bio xml:lang="en"><p>3, Bol. Sukharevskaya sq., Moscow, 129090</p></bio><email xlink:type="simple">solonin@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Годков</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Godkov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>16</day><month>04</month><year>2016</year></pub-date><volume>18</volume><issue>1</issue><fpage>83</fpage><lpage>90</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хубутия М.Ш., Солонин С.А., Годков М.А., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Хубутия М.Ш., Солонин С.А., Годков М.А.</copyright-holder><copyright-holder xml:lang="en">Khubutiya M.S., Solonin S.A., Godkov M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/623">https://journal.transpl.ru/vtio/article/view/623</self-uri><abstract><p>Представлены данные о распространенности, клинической значимости и методах лабораторной диагностики скрытых форм гемоконтактных вирусных инфекций (ГВИ). Рассмотрены причины возникновения таких форм инфекции и их значимость для клинической трансплантологии. Проанализирован существующий алгоритм лабораторного обследования потенциального донора органов на ГВИ в РФ. Показано, что действующий алгоритм скрининга доноров на ГВИ не позволяет выявлять скрытые формы инфекции.</p></abstract><trans-abstract xml:lang="en"><p>It provided data on the prevalence, clinical signifi cance and methods of laboratory diagnostics for occult forms of blood-borne viral infections (BBVIs). It considered causes of such forms of infection and their signifi cance for clinical transplantation. We analyzed the existing algorithm of laboratory screening of a potential organ donor for BBVIs in Russia. It is shown that the current screening algorithm doesn’t allow detecting hidden forms of BBVIs.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>скрытая HBV-инфекция</kwd><kwd>скрытая HCV-инфекция</kwd><kwd>потенциальный донор органов</kwd><kwd>трансплантация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>occult HBV infection</kwd><kwd>occult HCV infection</kwd><kwd>potential organ donor</kwd><kwd>transplantation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Хубутия МШ, ред. Трансплантация органов и тканей в многопрофильном научном центре. М.: АирАрт, 2011; 424. Hubutiya MSh, red. Organ and tissue transplantation in a multifi eld scientifi c center. M.: AirArt, 2011; 424.</mixed-citation><mixed-citation xml:lang="en">Хубутия МШ, ред. Трансплантация органов и тканей в многопрофильном научном центре. М.: АирАрт, 2011; 424. Hubutiya MSh, red. Organ and tissue transplantation in a multifi eld scientifi c center. M.: AirArt, 2011; 424.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">http://www.who.int [Internet]. WHO Media centre. HIV/AIDS; [updated 2014 November; cited 2015 Apr 10]. Available from: http://www.who.int/mediacentre/factsheets/fs360/en/.</mixed-citation><mixed-citation xml:lang="en">http://www.who.int [Internet]. WHO Media centre. HIV/AIDS; [updated 2014 November; cited 2015 Apr 10]. Available from: http://www.who.int/mediacentre/factsheets/fs360/en/.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">http://www.who.int [Internet]. WHO Media centre. Hepatitis B; [updated 2014 Jul; cited 2015 Apr 10]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.</mixed-citation><mixed-citation xml:lang="en">http://www.who.int [Internet]. WHO Media centre. Hepatitis B; [updated 2014 Jul; cited 2015 Apr 10]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">http://www.who.int [Internet]. WHO Media centre. Hepatitis C; [updated 2014 Apr; cited 2015 Apr 10]. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.</mixed-citation><mixed-citation xml:lang="en">http://www.who.int [Internet]. WHO Media centre. Hepatitis C; [updated 2014 Apr; cited 2015 Apr 10]. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ющук НД, Климова ЕА, Знойко ОО, Кареткина ГН, Максимов СЛ, Маев ИВ. Вирусные гепатиты: клиника, диагностика, лечение. М.: ГЭОТАР-Медиа, 2014; 151. Yushchuk ND, Klimova EA, Znoyko OO, Karetkina GN, Maksimov SL, Maev IV. Viral hepatitis: clinical features, diagnosis, treatment. M.: GEOTAR-Media, 2014; 151.</mixed-citation><mixed-citation xml:lang="en">Ющук НД, Климова ЕА, Знойко ОО, Кареткина ГН, Максимов СЛ, Маев ИВ. Вирусные гепатиты: клиника, диагностика, лечение. М.: ГЭОТАР-Медиа, 2014; 151. Yushchuk ND, Klimova EA, Znoyko OO, Karetkina GN, Maksimov SL, Maev IV. Viral hepatitis: clinical features, diagnosis, treatment. M.: GEOTAR-Media, 2014; 151.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2013 г. Гос. доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2014; 191. http://rospotrebnadzor.ru/upload/iblock/3b8/gd_2013_dlya-sayta.pdf. http://www.rospotrebnadzor.ru/[Internet]. About the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2013: state report. Moscow: Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 2014; 191. [updated 2014; cited 2015 Apr 10] Available from: http://rospotrebnadzor.ru/upload/iblock/3b8/gd_2013_dlya-sayta.pdf.</mixed-citation><mixed-citation xml:lang="en">О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2013 г. Гос. доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2014; 191. http://rospotrebnadzor.ru/upload/iblock/3b8/gd_2013_dlya-sayta.pdf. http://www.rospotrebnadzor.ru/[Internet]. About the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2013: state report. Moscow: Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 2014; 191. [updated 2014; cited 2015 Apr 10] Available from: http://rospotrebnadzor.ru/upload/iblock/3b8/gd_2013_dlya-sayta.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ison MG, Llata E, Conover CS, Friedewald JJ, Gerber SI, Grigoryan A et al. HIV-HCV Transplantation Transmission Investigation Team. Transmission of human immunodefi ciency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant. 2011; 11 (6): 1218–1225. doi: 10.1111/j.1600-6143.2011.03597.x. PMID: 21645254</mixed-citation><mixed-citation xml:lang="en">Ison MG, Llata E, Conover CS, Friedewald JJ, Gerber SI, Grigoryan A et al. HIV-HCV Transplantation Transmission Investigation Team. Transmission of human immunodefi ciency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant. 2011; 11 (6): 1218–1225. doi: 10.1111/j.1600-6143.2011.03597.x. PMID: 21645254</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Katchaki JN, Siem TH, Brouwer R. Serological evidence of presence of HBsAg undetectable by conventional radioimmunoassay in anti-HBc positive blood donor. J Clin Pathol. 1978; 31 (9): 837–839. PMID: 711912.</mixed-citation><mixed-citation xml:lang="en">Katchaki JN, Siem TH, Brouwer R. Serological evidence of presence of HBsAg undetectable by conventional radioimmunoassay in anti-HBc positive blood donor. J Clin Pathol. 1978; 31 (9): 837–839. PMID: 711912.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49 (4): 652–657. doi: 10.1016/j.jhep.2008.07.014. PMID: 18715666.</mixed-citation><mixed-citation xml:lang="en">Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49 (4): 652–657. doi: 10.1016/j.jhep.2008.07.014. PMID: 18715666.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010 Jan; 17 (1): 1–15. doi: 10.1111/j.1365-2893.2009.01245.x. PMID: 20002296.</mixed-citation><mixed-citation xml:lang="en">Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010 Jan; 17 (1): 1–15. doi: 10.1111/j.1365-2893.2009.01245.x. PMID: 20002296.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J. Med. Virol. 2004; 73: 195–199. PMID: 15122792.</mixed-citation><mixed-citation xml:lang="en">Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J. Med. Virol. 2004; 73: 195–199. PMID: 15122792.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008; 48 (5): 1001–1026. doi: 10.1111/j.1537-2995.2008.01701.x. PMID: 18454738.</mixed-citation><mixed-citation xml:lang="en">Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008; 48 (5): 1001–1026. doi: 10.1111/j.1537-2995.2008.01701.x. PMID: 18454738.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gutiérrez-García ML, Fernandez-Rodriguez CM, LledoNavarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17 (12): 1538–1542. doi: 10.3748/wjg.v17.i12.1538. PMID: 21472117.</mixed-citation><mixed-citation xml:lang="en">Gutiérrez-García ML, Fernandez-Rodriguez CM, LledoNavarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17 (12): 1538–1542. doi: 10.3748/wjg.v17.i12.1538. PMID: 21472117.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Fang M, Gu X, Ji Q, Li D, Cheng SQ et al. The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China. PLoS One. 2014; 9 (9): e107162. doi: 10.1371/journal.pone.0107162. PMID: 25229710.</mixed-citation><mixed-citation xml:lang="en">Wang H, Fang M, Gu X, Ji Q, Li D, Cheng SQ et al. The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China. PLoS One. 2014; 9 (9): e107162. doi: 10.1371/journal.pone.0107162. PMID: 25229710.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat. 2007; 14 (Suppl. 1): 11–15. PMID: 17958637.</mixed-citation><mixed-citation xml:lang="en">Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat. 2007; 14 (Suppl. 1): 11–15. PMID: 17958637.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2001; 41 (9): 1093–1099. PMID: 11552064.</mixed-citation><mixed-citation xml:lang="en">Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2001; 41 (9): 1093–1099. PMID: 11552064.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis. 2012; 32 (3): 228–236. doi: 10.1055/s-0032-1323628. PMID: 22932971.</mixed-citation><mixed-citation xml:lang="en">Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis. 2012; 32 (3): 228–236. doi: 10.1055/s-0032-1323628. PMID: 22932971.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Allain JP, Cox L. Challenges in hepatitis B detection among blood donors. Curr. Opin. Hematol. 2011; 18: 461–466. doi: 10.1097/MOH.0b013e32834bac10.</mixed-citation><mixed-citation xml:lang="en">Allain JP, Cox L. Challenges in hepatitis B detection among blood donors. Curr. Opin. Hematol. 2011; 18: 461–466. doi: 10.1097/MOH.0b013e32834bac10.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gerlich W.H., Brener C., Saniewski M, Schüttler CG, Wend UC, Willems WR et al. Occult hepatitis B virus infection: detection and signifi cance. Dig Dis. 2010; 28 (1): 116–125. doi: 10.1159/000282074. PMID: 21912252.</mixed-citation><mixed-citation xml:lang="en">Gerlich W.H., Brener C., Saniewski M, Schüttler CG, Wend UC, Willems WR et al. Occult hepatitis B virus infection: detection and signifi cance. Dig Dis. 2010; 28 (1): 116–125. doi: 10.1159/000282074. PMID: 21912252.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлов МИ, Кюрегян КК. Молекулярно-биологические основы контроля вирусных гепатитов. М.: Икар, 2013; 336. Mikhailov MI, Kyuregyan KK. Molecular and biological basis of control for viral hepatitis. M.: Ikar, 2013; 336.</mixed-citation><mixed-citation xml:lang="en">Михайлов МИ, Кюрегян КК. Молекулярно-биологические основы контроля вирусных гепатитов. М.: Икар, 2013; 336. Mikhailov MI, Kyuregyan KK. Molecular and biological basis of control for viral hepatitis. M.: Ikar, 2013; 336.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sticchi L, Caligiuri P, Cacciani R, Alicino C, Bruzzone B. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Hum Vaccin Immunother. 2013; 9 (3): 568–571. PMID: 23296324</mixed-citation><mixed-citation xml:lang="en">Sticchi L, Caligiuri P, Cacciani R, Alicino C, Bruzzone B. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Hum Vaccin Immunother. 2013; 9 (3): 568–571. PMID: 23296324</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Баженов АИ, Коноплева МВ, Фельдшерова АА, Эльгорт ДА, Хац ЮС, Лапина НЕ и др. Оценка чувствительности коммерческих тест-систем для иммунодетекции HBsAg по их способности выявлять HBsAg-мутанты вируса гепатита В. Журнал микробиологии, эпидемиологии и иммунобиологии. 2008; 3: 48–52. Bazhenov AI, Konopleva MV, Fel'dsherova AA, El'gort DA, Khats IuS, Lapina NE et al. Assessment of sensitivity of commercial test-systems for HBsAg immunodetection according to their ability to detect HBsAgmutants of hepatitis B virus. Zh Mikrobiol Epidemiol Immunobiol. 2008; 3: 48–53. [In Russ, English abstract]. PMID: 18597996.</mixed-citation><mixed-citation xml:lang="en">Баженов АИ, Коноплева МВ, Фельдшерова АА, Эльгорт ДА, Хац ЮС, Лапина НЕ и др. Оценка чувствительности коммерческих тест-систем для иммунодетекции HBsAg по их способности выявлять HBsAg-мутанты вируса гепатита В. Журнал микробиологии, эпидемиологии и иммунобиологии. 2008; 3: 48–52. Bazhenov AI, Konopleva MV, Fel'dsherova AA, El'gort DA, Khats IuS, Lapina NE et al. Assessment of sensitivity of commercial test-systems for HBsAg immunodetection according to their ability to detect HBsAgmutants of hepatitis B virus. Zh Mikrobiol Epidemiol Immunobiol. 2008; 3: 48–53. [In Russ, English abstract]. PMID: 18597996.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Чирский ВС. Биопсийная диагностика неопухолевых заболеваний печени. СПб.: СПб МАПО, 2009. 80. Chirskiy VS. Biopsy diagnostics of nonneoplastic diseases of the liver. SPb.: SPb MAPO, 2009. 80.</mixed-citation><mixed-citation xml:lang="en">Чирский ВС. Биопсийная диагностика неопухолевых заболеваний печени. СПб.: СПб МАПО, 2009. 80. Chirskiy VS. Biopsy diagnostics of nonneoplastic diseases of the liver. SPb.: SPb MAPO, 2009. 80.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014; 6 (12): 860–869. doi: 10.4254/wjh.v6.i12.860. PMID: 25544873.</mixed-citation><mixed-citation xml:lang="en">Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014; 6 (12): 860–869. doi: 10.4254/wjh.v6.i12.860. PMID: 25544873.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol. 2010; 52 (2): 272–279. doi: 10.1016/j.jhep.2009.11.009. PMID: 20034693.</mixed-citation><mixed-citation xml:lang="en">Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol. 2010; 52 (2): 272–279. doi: 10.1016/j.jhep.2009.11.009. PMID: 20034693.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung CK, Lo CM, Man K, Lau GK. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis. Liver Transpl. 2010; 16 (11): 1314–1323. doi: 10.1002/lt.22169. PMID: 21031547.</mixed-citation><mixed-citation xml:lang="en">Cheung CK, Lo CM, Man K, Lau GK. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis. Liver Transpl. 2010; 16 (11): 1314–1323. doi: 10.1002/lt.22169. PMID: 21031547.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Seetharam A, Perrillo R, Gish R. Immunosuppression in Patients with Chronic Hepatitis B. Curr Hepatol Rep. 2014; 13: 235–244. PMID: 25101233.</mixed-citation><mixed-citation xml:lang="en">Seetharam A, Perrillo R, Gish R. Immunosuppression in Patients with Chronic Hepatitis B. Curr Hepatol Rep. 2014; 13: 235–244. PMID: 25101233.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Huang X, Hollinger FB. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat. 2014; 21 (3): 153–162. doi: 10.1111/jvh.12222. PMID: 24438677.</mixed-citation><mixed-citation xml:lang="en">Huang X, Hollinger FB. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat. 2014; 21 (3): 153–162. doi: 10.1111/jvh.12222. PMID: 24438677.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Schubert A, Michel D, Mertens T. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation. BMC Infect Dis. 2013; 13: 223. doi: 10.1186/1471-2334-13-223. PMID: 23679074.</mixed-citation><mixed-citation xml:lang="en">Schubert A, Michel D, Mertens T. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation. BMC Infect Dis. 2013; 13: 223. doi: 10.1186/1471-2334-13-223. PMID: 23679074.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai MC, Chen YT, Chien YS, Chen TC, Hu TH. Hepatitis B virus infection and renal transplantation. World J Gastroenterol. 2010; 16 (31): 3878–3887. PMID: 20712048.</mixed-citation><mixed-citation xml:lang="en">Tsai MC, Chen YT, Chien YS, Chen TC, Hu TH. Hepatitis B virus infection and renal transplantation. World J Gastroenterol. 2010; 16 (31): 3878–3887. PMID: 20712048.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chamorro C, Aparicio M. Infl uence of HBcAb positivity in the organ donor in heart transplantation. Med Intensiva. 2012; 36 (8): 563–570. doi: 10.1016/j.medin.2012.01.011. PMID: 22440791.</mixed-citation><mixed-citation xml:lang="en">Chamorro C, Aparicio M. Infl uence of HBcAb positivity in the organ donor in heart transplantation. Med Intensiva. 2012; 36 (8): 563–570. doi: 10.1016/j.medin.2012.01.011. PMID: 22440791.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez-Iñigo E, de Lucas S et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis. 2004; 189 (1): 7–14. PMID: 14702147.</mixed-citation><mixed-citation xml:lang="en">Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez-Iñigo E, de Lucas S et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis. 2004; 189 (1): 7–14. PMID: 14702147.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, Pardo M, Carreño V. Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol. 2006; 80 (22): 10972–10979. PMID: 17071928.</mixed-citation><mixed-citation xml:lang="en">Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, Pardo M, Carreño V. Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol. 2006; 80 (22): 10972–10979. PMID: 17071928.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Pham TNQ, Coffi n CS, Michalak T. Occult hepatitis C virus infection: what does it mean? Liver International. 2010; 30 (4): 502–511. doi: 10.1111/j.1478-231.2009.02193.x. PMID: 20070513.</mixed-citation><mixed-citation xml:lang="en">Pham TNQ, Coffi n CS, Michalak T. Occult hepatitis C virus infection: what does it mean? Liver International. 2010; 30 (4): 502–511. doi: 10.1111/j.1478-231.2009.02193.x. PMID: 20070513.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Barril G, Castillo I, Arenas MD, Espinosa M, GarciaValdecasas J, Garcia-Fernández N et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol. 2008; 19 (12): 2288–2292. doi: 10.1681/ASN.2008030293. PMID: 18684893.</mixed-citation><mixed-citation xml:lang="en">Barril G, Castillo I, Arenas MD, Espinosa M, GarciaValdecasas J, Garcia-Fernández N et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol. 2008; 19 (12): 2288–2292. doi: 10.1681/ASN.2008030293. PMID: 18684893.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol. 2009; 81 (7): 1198–1203. doi: 10.1002/jmv.21483. PMID: 19475603.</mixed-citation><mixed-citation xml:lang="en">Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol. 2009; 81 (7): 1198–1203. doi: 10.1002/jmv.21483. PMID: 19475603.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh V, Palli D et al. Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One. 2009; 4 (12): e8128. doi: 10.1371/journal. pone.0008128. PMID: 19956542.</mixed-citation><mixed-citation xml:lang="en">De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh V, Palli D et al. Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One. 2009; 4 (12): e8128. doi: 10.1371/journal. pone.0008128. PMID: 19956542.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ison MG, Llata E, Conover CS, Friedewald JJ, Gerber SI, Grigoryan A et al. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant. 2011; 11 (6): 1218–12125. doi: 10.1111/j.1600-6143.2011.03597.x. PMID: 21645254.</mixed-citation><mixed-citation xml:lang="en">Ison MG, Llata E, Conover CS, Friedewald JJ, Gerber SI, Grigoryan A et al. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant. 2011; 11 (6): 1218–12125. doi: 10.1111/j.1600-6143.2011.03597.x. PMID: 21645254.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Centers for Disease Control and Prevention (CDC). Transmission of hepatitis C virus through transplanted organs and tissue – Kentucky and Massachusetts, 2011. MMWR Morb Mortal Wkly Rep. 2011; 60 (50): 1697–700. Erratum in: MMWR Morb Mortal Wkly Rep. 2012; 61: 80. PMID: 22189891.</mixed-citation><mixed-citation xml:lang="en">Centers for Disease Control and Prevention (CDC). Transmission of hepatitis C virus through transplanted organs and tissue – Kentucky and Massachusetts, 2011. MMWR Morb Mortal Wkly Rep. 2011; 60 (50): 1697–700. Erratum in: MMWR Morb Mortal Wkly Rep. 2012; 61: 80. PMID: 22189891.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Мазус АИ, Каминский ГД, Зимина ВН, Бессараб ТП, Пронин АЮ, Цыганова ЕВ и др. Национальные клинические рекомендации по диагностике и лечению ВИЧ-инфекции у взрослых. 2-е изд. М., 2014; 75. Mazus AI, Kaminskiy GD, Zimina VN, Bessarab TP, Pro nin AJu, Tsyganova EV et al. National clinical guidelines for the diagnosis and treatment of HIV infection in adults. Second edition. M., 2014; 75.</mixed-citation><mixed-citation xml:lang="en">Мазус АИ, Каминский ГД, Зимина ВН, Бессараб ТП, Пронин АЮ, Цыганова ЕВ и др. Национальные клинические рекомендации по диагностике и лечению ВИЧ-инфекции у взрослых. 2-е изд. М., 2014; 75. Mazus AI, Kaminskiy GD, Zimina VN, Bessarab TP, Pro nin AJu, Tsyganova EV et al. National clinical guidelines for the diagnosis and treatment of HIV infection in adults. Second edition. M., 2014; 75.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Borchi B, Ambu S, Bresci S, Zanazzi M, Salvadori M, Leoncini F. Case report: HIV infection from a kidney transplant. Transplant Proc. 2010; 42 (6): 2267–2269. doi: 10.1016/j.transproceed.2010.05.026. PMID: 20692460.</mixed-citation><mixed-citation xml:lang="en">Borchi B, Ambu S, Bresci S, Zanazzi M, Salvadori M, Leoncini F. Case report: HIV infection from a kidney transplant. Transplant Proc. 2010; 42 (6): 2267–2269. doi: 10.1016/j.transproceed.2010.05.026. PMID: 20692460.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhopadhyay P, Kumar V, Rathi M, Kohli HS, Jha V, Sakhuja V. Transmission of human immunodefi ciency virus infection by renal transplantation. Indian J Nephrol. 2012; 22 (2): 133–135. doi: 10.4103/0971-4065.97135. PMID: 22787317.</mixed-citation><mixed-citation xml:lang="en">Mukhopadhyay P, Kumar V, Rathi M, Kohli HS, Jha V, Sakhuja V. Transmission of human immunodefi ciency virus infection by renal transplantation. Indian J Nephrol. 2012; 22 (2): 133–135. doi: 10.4103/0971-4065.97135. PMID: 22787317.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt M, Korn K, Nübling CM, Chudy M, Kress J, Horst HA et al. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion. 2009; 49 (9): 1836–1844. doi: 10.1111/j.1537-2995.2009.02203.x. PMID: 19453990.</mixed-citation><mixed-citation xml:lang="en">Schmidt M, Korn K, Nübling CM, Chudy M, Kress J, Horst HA et al. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion. 2009; 49 (9): 1836–1844. doi: 10.1111/j.1537-2995.2009.02203.x. PMID: 19453990.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Щербук ЮА, Багненко СФ, Гриненко ОА, Полушин ЮС, Логинов ИВ, Бутина ЛВ и др. Дефицит донорских органов: причины, проблемы, пути решения. Вестник анестезиологии и реаниматологии. 2011; 2: 31–42. Shcherbuk YuA, Bagnenko SF, Grinenko OA, Polushin YuS, Loginov IV, Butina LV et al. Shortage of donor organs: reasons, problems, ways of solution. Vestnik anesteziologii i reanimatologii. 2011; 2: 31–42. [In Russ, English abstract].</mixed-citation><mixed-citation xml:lang="en">Щербук ЮА, Багненко СФ, Гриненко ОА, Полушин ЮС, Логинов ИВ, Бутина ЛВ и др. Дефицит донорских органов: причины, проблемы, пути решения. Вестник анестезиологии и реаниматологии. 2011; 2: 31–42. Shcherbuk YuA, Bagnenko SF, Grinenko OA, Polushin YuS, Loginov IV, Butina LV et al. Shortage of donor organs: reasons, problems, ways of solution. Vestnik anesteziologii i reanimatologii. 2011; 2: 31–42. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Хубутия МШ, Солонин СА, Годков МА, Баженов АИ, Кобзева ЕН, Смирнова ЮВ и др. Эпидемиологические и медико-социальные особенности распространения гемоконтактных вирусных инфекций у потенциальных доноров органов и доноров крови. Вестник службы крови России. 2014; 1: 17–24. Khubutiya MSh, Solonin SA, Godkov MA, Bazhenov AI, Kobzeva EN, Smirnova YuV et al. Epidemiological and medical-social features of the spread of bloodborne infectious diseases among potential organ donors and blood donors. Vestnik sluzhby krovi Rossii. 2014; 1: 17–24. [In Russ, English abstract].</mixed-citation><mixed-citation xml:lang="en">Хубутия МШ, Солонин СА, Годков МА, Баженов АИ, Кобзева ЕН, Смирнова ЮВ и др. Эпидемиологические и медико-социальные особенности распространения гемоконтактных вирусных инфекций у потенциальных доноров органов и доноров крови. Вестник службы крови России. 2014; 1: 17–24. Khubutiya MSh, Solonin SA, Godkov MA, Bazhenov AI, Kobzeva EN, Smirnova YuV et al. Epidemiological and medical-social features of the spread of bloodborne infectious diseases among potential organ donors and blood donors. Vestnik sluzhby krovi Rossii. 2014; 1: 17–24. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Решетников АВ. Социология медицины: руководство. М.: ГЭОТАР-Медиа, 2010. 863. Reshetnikov AV. Sociology of Medicine: guide. Moscow: GEOTAR-Media, 2010. 863.</mixed-citation><mixed-citation xml:lang="en">Решетников АВ. Социология медицины: руководство. М.: ГЭОТАР-Медиа, 2010. 863. Reshetnikov AV. Sociology of Medicine: guide. Moscow: GEOTAR-Media, 2010. 863.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Даниелян ШН, Годков МА, Абакумов ММ, Зубарева ОВ, Саприн АА. Медико-социальная характеристика пострадавших с гнойными осложнениями после закрытой травмы груди. Хирургия. 2013; 5: 19–25. Danielian ShN, Godkov MA, Abakumov MM, Zubareva OV, Saprin AA. Medical and social characteristics of patients with septic complications of the closed thoracic injury. Khirurgiia (Mosk). 2013; 5: 19–25. [In Russ, English abstract]. PMID: 23715417.</mixed-citation><mixed-citation xml:lang="en">Даниелян ШН, Годков МА, Абакумов ММ, Зубарева ОВ, Саприн АА. Медико-социальная характеристика пострадавших с гнойными осложнениями после закрытой травмы груди. Хирургия. 2013; 5: 19–25. Danielian ShN, Godkov MA, Abakumov MM, Zubareva OV, Saprin AA. Medical and social characteristics of patients with septic complications of the closed thoracic injury. Khirurgiia (Mosk). 2013; 5: 19–25. [In Russ, English abstract]. PMID: 23715417.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Смертность населения Москвы от причин, связанных с употреблением алкоголя, за январь–декабрь 2013 года http://77.rospotrebnadzor.ru/index.php/san-epid/40-2009-08-20-06-08-14/1909-san-epid. http://77.rospotrebnadzor.ru [Internet]. Mortality among Moscow’s citizens from causes related to alcohol consumption in January–December 2013. [updated 2013 Mar; cited 2015 Apr 10]. Available from: http://77.rospotrebnadzor.ru/index.php/san-epid/40-2009-08-20-06-08-14/1909-san-epid.</mixed-citation><mixed-citation xml:lang="en">Смертность населения Москвы от причин, связанных с употреблением алкоголя, за январь–декабрь 2013 года http://77.rospotrebnadzor.ru/index.php/san-epid/40-2009-08-20-06-08-14/1909-san-epid. http://77.rospotrebnadzor.ru [Internet]. Mortality among Moscow’s citizens from causes related to alcohol consumption in January–December 2013. [updated 2013 Mar; cited 2015 Apr 10]. Available from: http://77.rospotrebnadzor.ru/index.php/san-epid/40-2009-08-20-06-08-14/1909-san-epid.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Минина МГ. О некоторых аспектах организации органного донорства. Вестник трансплантологии и искусственных органов. 2010; 3: 81–88. Minina MG. To some organizational aspects of organ donation. Vestnik transplantologii i iskusstvennyh organov = Russian journal of transplantology and artifi cial organs. 2010; 3: 81–88. [In Russ, English abstract]. doi: 10.15825/1995-1191-2010-3.</mixed-citation><mixed-citation xml:lang="en">Минина МГ. О некоторых аспектах организации органного донорства. Вестник трансплантологии и искусственных органов. 2010; 3: 81–88. Minina MG. To some organizational aspects of organ donation. Vestnik transplantologii i iskusstvennyh organov = Russian journal of transplantology and artifi cial organs. 2010; 3: 81–88. [In Russ, English abstract]. doi: 10.15825/1995-1191-2010-3.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Shafer TJ, Schkade D, Schkade L, Geier SS, Orlowski JP, Klintmalm G. Zero risk tolerance costs lives: loss of transplantable organs due to human immunodefi ciency virus nucleic acid testing of potential donors. Prog. Transplant. 2011; 21 (3): 236–247. PMID: 21977885.</mixed-citation><mixed-citation xml:lang="en">Shafer TJ, Schkade D, Schkade L, Geier SS, Orlowski JP, Klintmalm G. Zero risk tolerance costs lives: loss of transplantable organs due to human immunodefi ciency virus nucleic acid testing of potential donors. Prog. Transplant. 2011; 21 (3): 236–247. PMID: 21977885.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Борт ГС, Иванов ИН, Савельев ВИ, Резник АГ, Рыков ЮА, Афиногенова АГ и др. Диагностика маркеров инфекционных заболеваний в перикардиальной жидкости и крови трупов доноров при заготовке тканей для трансплантации в травматологии и ортопедии. Травматология и ортопедия России. 2008; 2: 72–76. Bort GS, Ivanov IN, Savelev VI, Reznik AG, Rykov YuA, Afinogenova AG et al. The diagnostics of the markers of infectious diseases in the pericardial fl uid and blood of cadavers, donors at the purveyance of tissues for transplantation in traumatology and orthopedics. Traumatology and orthopedics of Russia. 2008; 2: 72–76. [In Russ, English abstract].</mixed-citation><mixed-citation xml:lang="en">Борт ГС, Иванов ИН, Савельев ВИ, Резник АГ, Рыков ЮА, Афиногенова АГ и др. Диагностика маркеров инфекционных заболеваний в перикардиальной жидкости и крови трупов доноров при заготовке тканей для трансплантации в травматологии и ортопедии. Травматология и ортопедия России. 2008; 2: 72–76. Bort GS, Ivanov IN, Savelev VI, Reznik AG, Rykov YuA, Afinogenova AG et al. The diagnostics of the markers of infectious diseases in the pericardial fl uid and blood of cadavers, donors at the purveyance of tissues for transplantation in traumatology and orthopedics. Traumatology and orthopedics of Russia. 2008; 2: 72–76. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Edler C, Wulff B, Schröder AS, Wilkemeyer I, Polywka S, Meyer T et al. A prospective time-course study on serological testing for human immunodefi ciency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death. J. Med. Microbiol. 2011; 60 (Pt7): 920–926. doi: 10.1099/jmm.0.027763-0. PMID: 21436373.</mixed-citation><mixed-citation xml:lang="en">Edler C, Wulff B, Schröder AS, Wilkemeyer I, Polywka S, Meyer T et al. A prospective time-course study on serological testing for human immunodefi ciency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death. J. Med. Microbiol. 2011; 60 (Pt7): 920–926. doi: 10.1099/jmm.0.027763-0. PMID: 21436373.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Theodoropoulos N, Ison MG, Jaramillo A. Screening deceased organ donors for infectious diseases: optimization of testing. ASHI Quarterly. 10/2012; 36 (3): 18–26.</mixed-citation><mixed-citation xml:lang="en">Theodoropoulos N, Ison MG, Jaramillo A. Screening deceased organ donors for infectious diseases: optimization of testing. ASHI Quarterly. 10/2012; 36 (3): 18–26.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B et al. Nucleic acid testing (NAT) of organ donors: is the ‘best’ test the right test? A consensus conference report. Am. J. Transplant. 2010; 10 (4): 889–899. doi: 10.1111/j.1600-6143.2009.02992.x. PMID: 20121734.</mixed-citation><mixed-citation xml:lang="en">Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B et al. Nucleic acid testing (NAT) of organ donors: is the ‘best’ test the right test? A consensus conference report. Am. J. Transplant. 2010; 10 (4): 889–899. doi: 10.1111/j.1600-6143.2009.02992.x. PMID: 20121734.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
